AUS
NZ
UK
CA
USA
IND
Healthcare
Healthcare Innovation Rises with NIOX Group Amid FTSE AIM 100 Developments
November 12, 2025 07:00 AM GMT| By Vivek SinghNIOX Group, listed on the FTSE AIM 100 Index, focuses on respiratory diagnostics within the healthcare sector, driving technological innovation across UK medical devices.
Ironwood Pharmaceuticals Strengthens its Healthcare Standing NYSE Composite Index
November 10, 2025 10:44 PM PST| By Anmol KhazanchiIronwood Pharmaceuticals (IRWD) reflects consistent activity within the healthcare segment, maintaining focus on gastrointestinal medicine while aligning with sector movements under the NYSE Composite Index.
ConvaTec Group Enhances Medical Innovation and Market Reach under FTSE 100
November 10, 2025 08:42 AM GMT| By Vivek SinghConvaTec Group Plc (LSE:CTEC), a leading entity within the FTSE 100, continues to strengthen its position in the healthcare sector through innovation, operational excellence, and sustainable business practices across global markets.
UK Blue-Chip Stock Sees Significant Shift on FTSE 100 Index Live
November 07, 2025 01:15 PM GMT| By Vivek SinghUK FTSE 100 value stock shows notable market movement, reflecting sector activity, industrial and financial exposure, and index dynamics across the UK market.
Spire Healthcare Group Expands Its FTSE 350 Presence Amid Sector Movements
November 07, 2025 06:23 AM GMT| By Vivek SinghSpire Healthcare Group plc (LSE:SPI), listed on the FTSE 350, continues to strengthen its role within the UK’s private healthcare ecosystem.
FT100 Futures Reflect AstraZeneca’s Record Momentum on the FTSE 100
November 06, 2025 09:23 AM GMT| By Vivek SinghAstraZeneca maintains a leading position on the FTSE 100, reflecting resilience and innovation across healthcare operations while aligning with FT100 Futures momentum.
Hutchmed Strengthens Position Within FTSE AIM 100 Index Healthcare Sphere
November 04, 2025 12:09 PM GMT| By Vivek SinghHutchmed (LSE:HCM), listed under the FTSE AIM 100 Index, continues to advance within the healthcare and biopharmaceutical field, reinforcing its focus on oncology and immunology innovation.
EKF Diagnostics Reflects Technical Movement Within FTSE AIM All-Share Index
November 04, 2025 10:25 AM GMT| By Vivek SinghEKF Diagnostics continues its operations within the FTSE AIM All-Share Index, supporting healthcare innovation through precision diagnostics and clinical technology.
Bioventix plc Corporate Update on FTSE AIM 100 Index
November 01, 2025 10:25 AM GMT| By Vivek SinghBioventix plc maintains a disciplined approach within the healthcare sector, focusing on antibody innovation and strong governance standards on the FTSE AIM 100 Index.
Bioventix Dividend Update Sparks Attention Across FTSE 100 Investors
October 30, 2025 06:13 AM GMT| By Vivek SinghBioventix PLC (LSE:BVXP) declares a new dividend, highlighting ongoing confidence in income-driven strategies within the LSE stock market and sparking attention among FTSE 100 participants.
FTSE 100 Strengthens as GSK Sparks Movement in the Healthcare Sector
October 29, 2025 11:54 AM GMT| By Vivek SinghFTSE 100 witnessed notable movement as GSK drew attention within healthcare. The pharmaceutical sector remained a steady pillar for overall index balance amid ongoing market variations.
GSK plc Strengthens Outlook with Steady Performance Across FTSE 100 Healthcare Segment
October 29, 2025 08:23 AM GMT| By Vivek SinghGSK plc reinforces its FTSE 100 position with a stronger outlook and consistent healthcare performance, supported by ongoing innovation and operational discipline.
Resilient progress for Ondine Biomedical amid FTSE AIM All-Share healthcare focus
October 28, 2025 10:03 AM GMT| By Vivek SinghOndine Biomedical PLC (LSE:OBI) drives progress in light-based infection prevention, aligning healthcare innovation and sustainability within the FTSE AIM All-Share.
FTSE AIM All-Share Firm ECO Animal Health Group plc Expands Global Reach in Animal Healthcare
October 28, 2025 06:06 AM GMT| By Team Kalkine MediaECO Animal Health Group plc (LSE:EAH), a FTSE AIM All-Share company, advances veterinary healthcare through ethical research, scientific innovation, and sustainable animal welfare practices.
EKF Diagnostics (LSE:EKF) Faces Market Dip Amid Broader FTSE 100 Movement
October 27, 2025 07:09 AM GMT| By Vivek SinghEKF Diagnostics (LSE:EKF) saw stock pressure amid FTSE 100 shifts, spotlighting the diagnostics industry’s evolving market trends and the company’s strategic manufacturing and global healthcare presence.
FTSE 100 Faces Listing Pressure as AstraZeneca Eyes US Market Shift
October 24, 2025 07:12 AM BST| By Vivek SinghAstraZeneca’s (LSE:AZN) planned US listing shift highlights UK market reform needs, sparking debate on stamp duty’s future and its impact on London’s global trading competitiveness and investor sentiment.
Avacta (LSE:AVCT) Raises £16 Million in Oversubscribed Placing to Advance Oncology Trials
October 20, 2025 08:22 AM BST| By Sonal GoyalHighlights,Avacta raised approximately,£16 million,through an oversubscribed placing of 25.4 million new shares at,63 pence each,.,The funds will support ongoing R&D programs, including,faridoxorubicin Phase 1b,and the planned,FAP-EXd Phase 1a trials...
IXICO (LSE:IXI) Boosts Biomarker Research Amid FTSE 100 News
October 15, 2025 09:04 AM BST| By Vivek SinghIXICO PLC (LSE:IXI) strengthens biomarker testing and Alzheimer’s research using AI-driven platforms, expanding clinical trials and reinforcing its impact in the FTSE 100 and LSE stock market.
Saudi Arabia Vaccines Market in FTSE 350 Healthcare Stocks
October 14, 2025 06:14 PM BST| By Vivek SinghSaudi Arabia's vaccine sector sees active participation from FTSE 350 healthcare, technology, and midcap stocks through research, production, and regional collaborations, supporting public health initiatives.
CRISM Therapeutics Boosts FTSE 100 Hopes with ChemoSeed Win
October 14, 2025 12:02 PM BST| By Vivek SinghThis article explores CRISM Therapeutics' innovative ChemoSeed platform, detailing its impact on prostate cancer treatment and market movement on the LSE.
